Compounds > naltrexone

naltrexone and Breast Cancer

naltrexone has been researched along with Breast Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Gupta, K; Haddad, T; Sauers, J; Vijayakumar, J; Yee, D1
Ashizawa, K; Hara, T; Ikeda, T; Ishii, K; Kamada, M; Komatsu, Y; Matsuo, K; Morishita, S; Ryu, E; Yamaguchi, M; Yamashita, H1
McLaughlin, PJ; Porterfield, NK; Zagon, IS1
Aung, HH; Li, XL; McEntee, E; Sun, S; Tong, R; Wang, CZ; Xie, JT; Yuan, CS1
Scholz, M1

Trials

1 trial(s) available for naltrexone and Breast Cancer

ArticleYear
An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer.
    Investigational new drugs, 2023, Volume: 41, Issue:1

    Topics: Breast Neoplasms; Female; Hormones; Humans; Naltrexone; Positron Emission Tomography Computed Tomography; Receptors, Estrogen

2023

Other Studies

5 other study(ies) available for naltrexone and Breast Cancer

ArticleYear
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
    Internal medicine (Tokyo, Japan), 2020, Jan-15, Volume: 59, Issue:2

    Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Oxycodone; Substance Withdrawal Syndrome

2020
Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.
    Experimental biology and medicine (Maywood, N.J.), 2013, Volume: 238, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Female; Humans; Naltrexone; Narcotic Antagonists; Opioid Peptides; Receptors, Opioid

2013
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Lung Neoplasms; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Tumor Cells, Cultured

2009
Managing constipation that's opioid-induced.
    RN, 2000, Volume: 63, Issue:6

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Breast Neoplasms; Chemistry, Pharmaceutical; Constipation; Female; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Quaternary Ammonium Compounds

2000
Interviews and anecdotal reports.
    Positive health news, 1998,Spring, Issue:No 16

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Neoplasms; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Complementary Therapies; Diet; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Naltrexone; Viral Load

1998